Skip to main content
. Author manuscript; available in PMC: 2021 Jul 5.
Published in final edited form as: Mov Disord. 2020 Jul 11;35(10):1834–1842. doi: 10.1002/mds.28188

Figure 1.

Figure 1

(A) Mean [11C]UCB-J BPND maps for control participants (top row), CBD (middle row), and PSP (bottom row); high and low BPND values are shown by red and blue areas, respectively.

(B) Reduction in global [11C]UCB-J BPND across patients compared to controls (P<0.05).

(C) Individual regional GTM PVC [11C]UCB-J BPND values for control, CBD and PSP participants, across major regions of interests. Binding potential values for patients differed significantly from controls in all the regions depicted (P<0.05, FDR corrected).